|
|
|
|
|
Detail |
| hsa-miR-222 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
MicroRNA expression profiling in prostate cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. |
2007 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. |
2007 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
MicroRNAs play an essential role in the development of cardiac hypertrophy. |
2008 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. |
2007 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Causal |
The role of microRNA genes in papillary thyroid carcinoma. |
2005 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Causal |
MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Causal |
Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Causal |
miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. |
2007 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. |
2008 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Causal |
The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. |
2008 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. |
2008 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. |
2009 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
miRNA Expression in a Human Papillary Thyroid Carcinoma Cell Line Varies with Invasiveness |
2009 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. |
2008 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1. |
2008 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Causal |
MicroRNA-221/222 Negatively Regulates Estrogen Receptor{alpha} and Is Associated with Tamoxifen Resistance in Breast Cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Causal |
MicroRNA profile analysis of human prostate cancers. |
2008 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Causal |
MicroRNA-221 and -222 pathway controls melanoma progression. |
2008 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Causal |
Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222,miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. |
2009 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Causal |
The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer
cell lines. |
2009 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Effect of atorvastatin on microRNA 221 / 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. |
2009 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Causal |
Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. |
2009 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Causal |
MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1(MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell
carcinoma cell lines. |
2009 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumours associates with poorer survival. |
2009 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumours associates with poorer survival. |
2009 |
|
|
|
|
|
|